{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T16:57:10Z","timestamp":1772384230688,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471221"],"award-info":[{"award-number":["81471221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Research Program of Application Foundation and Advanced Technology","award":["15JCZDJC35700"],"award-info":[{"award-number":["15JCZDJC35700"]}]},{"name":"National Key Clinical Specialty Construction Project of China"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cca.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T10:01:50Z","timestamp":1486202510000},"page":"5-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"468","author":[{"given":"Lin-Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Mei","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.02.003_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barre syndrome","volume":"6","author":"van Koningsveld","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0010","article-title":"Subtypes and prognosis of Guillain-Barre Syndrome in Southwest China","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2017.02.003_bb0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barre syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol. Clin."},{"issue":"Pt 3","key":"10.1016\/j.cca.2017.02.003_bb0020","first-page":"597","article-title":"Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0140-6736(91)90606-P","article-title":"Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China","volume":"338","author":"McKhann","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2017.02.003_bb0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal Guillain-Barre syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2010.09.017","article-title":"Guillain-Barre syndrome: clinical variants and their pathogenesis","volume":"231","author":"Winer","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2017.02.003_bb0045","doi-asserted-by":"crossref","first-page":"758639","DOI":"10.1155\/2014\/758639","article-title":"Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barre syndrome","volume":"2014","author":"Nyati","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2017.02.003_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cyto.2015.01.030","article-title":"Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease","volume":"75","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2017.02.003_bb0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2017.02.003_bb0060","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2017.02.003_bb0065","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2017.02.003_bb0070","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3109\/08820139.2015.1043671","article-title":"IL-35 is involved in the pathogenesis of Guillain-Barre syndrome through its influence on the function of CD4+ T cells","volume":"44","author":"Liu","year":"2015","journal-title":"Immunol. Investig."},{"issue":"Suppl","key":"10.1016\/j.cca.2017.02.003_bb0075","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0080","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1468-1331.2008.02261.x","article-title":"The role of IL-12 and TNF-alpha in AIDP and AMAN","volume":"15","author":"Deng","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0085","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archneur.63.6.858","article-title":"Interleukin 23 in acute inflammatory demyelination of the peripheral nerve","volume":"63","author":"Hu","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-065X.2008.00704.x","article-title":"Interleukin-35: odd one out or part of the family?","volume":"226","author":"Collison","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cca.2017.02.003_bb0095","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.autrev.2015.08.001","article-title":"IL-27-induced modulation of autoimmunity and its therapeutic potential","volume":"14","author":"Meka","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2017.02.003_bb0100","first-page":"76","article-title":"Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses","volume":"9","author":"Portielje","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2017.02.003_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2015.09.010","article-title":"Serum interleukin-27 expression in patients with myasthenia gravis","volume":"288","author":"Jeong","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2017.02.003_bb0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2014.11.035","article-title":"Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis","volume":"348","author":"Tang","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2017.02.003_bb0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14728221003769911","article-title":"Therapeutic potential of IL-27 in systemic lupus erythematosus","volume":"14","author":"Pan","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cca.2017.02.003_bb0120","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2007.083360","article-title":"Interleukin 27 attenuates collagen-induced arthritis","volume":"67","author":"Niedbala","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2017.02.003_bb0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cca.2017.02.003_bb0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAJ.0000000000000215","article-title":"Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus","volume":"348","author":"Ouyang","year":"2014","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.cca.2017.02.003_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1620\/tjem.237.77","article-title":"Low serum levels of interleukin 35 in patients with rheumatoid arthritis","volume":"237","author":"Ning","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.cca.2017.02.003_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2014.06.002","article-title":"The expression of a novel anti-inflammatory cytokine IL-35 and its possible significance in childhood asthma","volume":"162","author":"Ma","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cca.2017.02.003_bb0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2174\/1381612820666141014123810","article-title":"Novel anti-inflammatory interleukin-35 as an emerging target for antiatherosclerotic therapy","volume":"21","author":"Bobryshev","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cca.2017.02.003_bb0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","article-title":"Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barre syndrome","volume":"192","author":"Chi","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2017.02.003_bb0155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","article-title":"Guillain-Barre syndrome: a century of progress","volume":"12","author":"Goodfellow","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2017.02.003_bb0160","article-title":"Zika virus infection and Guillain-Barre syndrome: a review focused on clinical and electrophysiological subtypes","author":"Uncini","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2017.02.003_bb0165","first-page":"19","article-title":"Zika virus infection complicated by Guillain-Barre syndrome\u2014case report, French Polynesia, December 2013","author":"Oehler","year":"2014","journal-title":"Euro Surveill."},{"key":"10.1016\/j.cca.2017.02.003_bb0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fneur.2016.00170","article-title":"Zika virus and Guillain-Barre syndrome: is there sufficient evidence for causality?","volume":"7","author":"Leis","year":"2016","journal-title":"Front. Neurol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117300475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117300475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T11:21:17Z","timestamp":1536060077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117300475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":34,"alternative-id":["S0009898117300475"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.02.003","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}